4LX-26884-71210

2 vaccinations 19 coded responses 25 check-ins 19 free-text entries 3 call cases

Sex: Female
Age at first dose: 61-65
ZIP prefix: 775 / TX
Registered: 2021-03-18

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-18
Registered in v-safe
2021-03-18
Dose 1 — Pfizer-BioNTech
2021-03-18
Health check-in — day 0, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-19
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Itching · Headache · Be unable to do your normal daily activities

Adult check-in
2021-03-20
Survey response — days 1–6 daily, dose 1
MedDRA: Pruritus, Respiratory tract congestion — Feeling: Poor · Site: Itching · Fever · Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Itching, congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-20
Report sent to call center — days 1–6 daily, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-21
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea — Feeling: Poor · Site: Itching · Fever · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Breathing difficulty

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-22
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea — Feeling: Fair · Site: Redness, Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Breathing difficulty

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Itching · Headache, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-03-23
Report sent to call center — days 1–6 daily, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-24
Survey response — days 1–6 daily, dose 1
MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — day 7, dose 1
MedDRA: Pruritus — Feeling: Fair · Site: Itching · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Itching

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-08
Dose 2 — Pfizer-BioNTech
2021-04-08
Survey response — day 0, dose 2
MedDRA: Pruritus — Feeling: Fair · Site: Itching · Fever · Be unable to do your normal daily activities

Free text: Itching

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Pruritus — Feeling: Fair · Site: Itching · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Itching, breathing difficulties

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Pruritus — Feeling: Fair · Site: Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Itching breathing difficulties

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Medical counselling, Pruritus — Feeling: Poor · Site: Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Itching, breathing difficulties · Healthcare visit (other): Home health

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-12
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Fatigue, Pruritus — Feeling: Fair · Site: Itching · Fever · Headache, Joint pains · Be unable to do your normal daily activities

Free text: Itching, dizziness, fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Survey response — days 1–6 daily, dose 2
MedDRA: Pruritus — Feeling: Good · Site: Itching · Fever · Fatigue or tiredness

Free text: Itching

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Fatigue or tiredness

Adult check-in
2021-04-15
Health check-in — day 7, dose 2
Feeling: Good · Site: Itching · Headache, Fatigue or tiredness

Adult check-in
2021-04-22
Survey response — day 14, dose 2
MedDRA: Fatigue, Pruritus — Feeling: Good · Be unable to do your normal daily activities

Free text: Itching and fatigue are worse.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Survey response — day 21, dose 2
MedDRA: Blood glucose increased, Hypertension, Pruritus, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activities

Free text: ItchingCongestionHigh blood pressure High blood sugar

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — day 28, dose 2
MedDRA: Dyspnoea, Fatigue, Pruritus — Feeling: Fair · Be unable to do your normal daily activities

Free text: ItchingBreathing difficulty Fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-13
Survey response — day 35, dose 2
MedDRA: Dyspnoea, Fatigue, Pruritus — Feeling: Fair · Be unable to do your normal daily activities

Free text: Breathing difficulties ItchingFatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Survey response — day 42, dose 2
MedDRA: Asthma, Dysphagia, Dyspnoea, Fatigue, Insomnia, Respiratory tract congestion, Sleep disorder — Feeling: Good · Be unable to do your normal daily activities

Free text: Asthma/breathing/congestionSwallowing difficulty Sleep disruption

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-08
Survey response — 3 months, dose 2
MedDRA: Arthralgia, Dyspnoea, Headache, Myalgia, Panic attack, Pruritus, Sleep disorder — Feeling: Fair · Be unable to do your normal daily activities

Free text: ItchingPanic attacks Breathing difficulty HeadacheJoint painMuscle painContinuing sleep issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-07
Survey response — 6 months, dose 2
MedDRA: Muscle spasms, Platelet count decreased, Sleep disorder — Feeling: Fair · Be unable to do your normal daily activities

Free text: Platelets dropped over 50 points Fibrin in blood samples indicating possible development of blood clots Extreme muscle cramps in both legs, both feet, both hands, and back Sleep issues are worse.

MedDRA releases: 2024-11 · check-in free text available
2021-12-22
Call 1 — Left Voicemail
2021-12-22
Call successful
Participant prefers to complete VAERS report online
2022-04-08
Survey response — 12 months, dose 2
MedDRA: Arthralgia, Decreased appetite, Dizziness, Dyspnoea, Fatigue, Insomnia, Myalgia, Pyrexia, Taste disorder — Feeling: Poor · Be unable to do your normal daily activities

Free text: Dizziness, no Appetite, change in taste, sleepless, extreme fatigue, fever over 102 for more than a week, muscle and joint pain, breathing difficulty

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-18	Pfizer-BioNTech
2	2021-04-08	Pfizer-BioNTech

Call center

3 call center cases

3 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): Itching, congestion

2021-03-21

Systemic reaction (other): Breathing difficulty

2021-03-22

Systemic reaction (other): Breathing difficulty

2021-03-24

Systemic reaction (other): Congestion

Release 6 — day 7, dose 1

2021-03-25

Systemic reaction (other): Itching

Release 7 — day 0, dose 2

2021-04-08

Systemic reaction (other): Itching

Release 7 — days 1–6 daily, dose 2

2021-04-09

Systemic reaction (other): Itching, breathing difficulties

2021-04-10

Systemic reaction (other): Itching breathing difficulties

2021-04-11

Systemic reaction (other): Itching, breathing difficulties

Healthcare visit (other): Home health

2021-04-12

Systemic reaction (other): Itching, dizziness, fatigue

2021-04-13

Systemic reaction (other): Itching

Release 7 — day 14, dose 2

2021-04-22

Symptoms: Itching and fatigue are worse.

Release 8 — day 21, dose 2

2021-04-29

Symptoms: ItchingCongestionHigh blood pressure High blood sugar

Release 8 — day 28, dose 2

2021-05-06

Symptoms: ItchingBreathing difficulty Fatigue

Release 8 — day 35, dose 2

2021-05-13

Symptoms: Breathing difficulties ItchingFatigue

Release 8 — day 42, dose 2

2021-05-20

Symptoms: Asthma/breathing/congestionSwallowing difficulty Sleep disruption

Release 9 — 3 months, dose 2

2021-07-08

Symptoms: ItchingPanic attacks Breathing difficulty HeadacheJoint painMuscle painContinuing sleep issues

Release 10 — 6 months, dose 2

2021-10-07

Symptoms: Platelets dropped over 50 points Fibrin in blood samples indicating possible development of blood clots Extreme muscle cramps in both legs, both feet, both hands, and back Sleep issues are worse.

Release 11 — 12 months, dose 2

2022-04-08

Symptoms: Dizziness, no Appetite, change in taste, sleepless, extreme fatigue, fever over 102 for more than a week, muscle and joint pain, breathing difficulty

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	✓	✓	✓
SD	Arthralgia	✓	✓	✓
SD	Asthma	·	·	✓
SD	Blood glucose increased	✓	✓	✓
SD	Decreased appetite	·	·	✓
SD	Dizziness	·	·	✓
SD	Dysphagia	·	·	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Insomnia	✓	✓	✓
SD	Muscle spasms	·	·	✓
SD	Myalgia	✓	✓	✓
SD	Panic attack	✓	✓	✓
SD	Platelet count decreased	·	·	✓
SD	Pruritus	✓	✓	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Sleep disorder	✓	✓	✓
SD	Taste disorder	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	Pruritus	✓	✓	✓
SRO	Respiratory tract congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release